VivoPlex, a UK based firm specialising in fertility and women’s health, has raised £3.9m to develop an intra-uterine sensor system and generate clinical data that could be used for European
NHSX, the government agency tasked with digitally transforming the UK’s health service, has launched a service to help hospitals and clinics select pre-approved products to replace pagers.<
Medical device company Indigo Diabetes has raised 38 million euros to develop an “invisible” sensor for people with diabetes, which could provide an alternative to the “patch” based monitor
The UK government is providing funding to bring a software tool used to monitor patients during surgery to market “as soon as possible”, says its developer.
US biotech AI Therapeutics has begun a phase 2 trial of its LAM-002A, an antiviral drug that has shown promise against the SARS-CoV-2 coronavirus in the lab.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.